Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GL-SRF-001 (GILongevity)
- Development stage
- Preclinical
- Lead developer
- GILongevity
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
GL-SRF-001 is a recombinant fusion protein currently in the discovery stage, developed by GILongevity, a subsidiary of the South Korean biotechnology company GI Innovation. The drug is part of a specialized pipeline focused on regenerative medicine, specifically targeting skin and hair regeneration. While the precise molecular targets and mechanism of action have not been publicly detailed, the asset is designed to leverage fusion protein technology to stimulate tissue repair and cellular regeneration. It aims to address age-related conditions such as skin atrophy and hair loss by promoting the restoration of healthy tissue function and counteracting the biological decline associated with aging.
- Other names
- GL-SRF-001-GILongevity-fusion protein-skin & hair regeneration
Beyond the preview
Go deeper on GL-SRF-001 (GILongevity).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GL-SRF-001 (GILongevity).